Circular RNAs: Functions and Clinical Significance in Cardiovascular Disease

Lei Zhang1, Yuan Zhang1, Yin Wang1

  • 1Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.

Insights

Circular RNAs (circRNAs) are involved in cardiovascular disease (CVD) development. These stable, non-coding RNAs show potential as diagnostic and prognostic biomarkers for CVD.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cardiology

Background:

  • Cardiovascular disease (CVD) presents a significant global health challenge, contributing to high rates of morbidity and mortality.
  • Emerging research highlights the potential involvement of circular RNAs (circRNAs) in the underlying mechanisms of CVD.
  • CircRNAs are unique non-coding RNA molecules characterized by a stable, covalently closed loop structure.

Purpose of the Study:

  • To systematically review current knowledge on circRNA biogenesis, properties, and mechanisms of action.
  • To elucidate the roles of circRNAs in the pathogenesis of cardiovascular diseases.
  • To explore the diagnostic and prognostic potential of circRNAs in CVD.

Main Methods:

  • Literature review and systematic summary of existing research on circRNAs and CVD.
  • Analysis of circRNA functions, including miRNA sponging, protein interaction, transcriptional regulation, and translation.
  • Evaluation of circRNA characteristics (stability, expression patterns) for biomarker potential.

Main Results:

  • CircRNAs exhibit diverse functions, acting as miRNA sponges, RNA-binding protein sponges, and regulators of transcription and translation.
  • Their stability, abundance, and specific expression patterns position circRNAs as promising biomarkers for CVD diagnosis and prognosis.
  • Current research suggests significant roles for circRNAs in the complex pathogenesis of cardiovascular diseases.

Conclusions:

  • CircRNAs play multifaceted roles in CVD pathogenesis through various molecular mechanisms.
  • The unique properties of circRNAs offer significant potential for clinical applications in CVD diagnosis and prognosis.
  • Further research is expected to uncover more molecular mechanisms and advance the clinical utility of circRNAs in managing cardiovascular diseases.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.4K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.9K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
283
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
3.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
227